Answers are grounded in this paper and cite their sources.
A unique and unexpected syndrome consisting of metabolic abnormalities (hyperlipidaemia and insulin resistance) and body fat redistribution (central adiposity and peripheral fat wasting) has been reported with increasing frequency in HIV-1 infected patients, most of whom are receiving highly active antiretroviral therapies including HIV-1 protease inhibitors. This article reviews the clinical and laboratory characteristics, the pathogenesis, and the management of this syndrome.
No takes yet. Share an insight, caveat, or question.
Martínez et al. (1999) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: